OCBC Q1 Profit Rises 5% on Strong Wealth Management and Non-Interest Income 
GOP Lawmakers Probe Sam Altman and OpenAI Ahead of Potential IPO 
Trump Invites Top CEOs Including Nvidia, Apple, Boeing to China Summit With Xi Jinping 
US Auto Industry Urges Trump to Block Chinese EV Market Access 
Armani Group Eyes Strategic Stake Sale to Luxury Giants 
Sony Forecasts Lower 2027 Profit Despite Strong Music and Sensor Growth 
Goldman Sachs Delays Fed Rate Cut Forecast to 2026 Amid Rising Inflation Concerns 
Nike Tariff Refund Lawsuit Sparks Consumer Backlash Over Price Increases 
Judge Delays SEC Settlement With Elon Musk Over Twitter Stock Disclosure Case 
Morgan Stanley Bets on Optical Component Stocks in Greater China Tech Sector 
AWS Data Center Overheating Disrupts Cloud Services in Northern Virginia 
Kuaishou Stock Jumps on Kling AI IPO Plans and $20 Billion Valuation 
K+S Raises 2026 Earnings Outlook After Strong Q1 Results 
Orsted Q1 EBITDA Beats Expectations Despite U.S. Impairments 
TikTok Nears $400 Million Settlement With Trump Administration Over Child Privacy Lawsuit 
CSL Shares Crash as Profit Warning and $5 Billion Impairment Shake Investors 
Kolmar Korea, a Sejong City-headquartered pharmaceutical preparation manufacturing company, surpassed KRW2 trillion in annual sales for the first time since its founding in 1995. The company reached this milestone due to the immense growth of its subsidiary in China.
The company is looking to expand its market in the United States and will focus on its sunscreen products for this goal. Kolmar Korea can realize this plan as it has already laid the foundations for scaling up its business in the American market.
Targeting Bigger Market Share in the US
As per The Korea Times, Kolmar Korea is speeding up its market expansion in the U.S. market with its sunscreen products. The company prepared for this by obtaining product certification and setting up a new research and development center (R&D).
Kolmar Korea established the facility to better analyze the local consumer market and work on what is best to grow and expand to other regions. The company's primary target today is boosting the sales and demand for its sunscreen in the country since this will equate to success.
It was reported that the largest sunscreen developer in the country is targeting the U.S. because it has the most expansive market for sunscreens.
Big Sucess in China
Meanwhile, as it aims for U.S. expansion, the company is doing well in China. It hit KRW2 trillion in annual sales for the first time. Korea's Consumer News reported that Kolmar Korea said the main reason for the surge in sales was the growth of small and medium-sized indie brands in the country.
It was noted that the firm's ODM (Original Design Manufacturing) and OEM (Original Equipment Manufacturing) are remarkable and played prominent roles in raking in big sales in the territory. Kolmar Korea's Chinese subsidiary also accounts for the second-highest sales share after Korea, so the brand achieved a good performance in 2023.
"A potential for growth in the North American market, including the U.S., is limitless as sunscreen functions are incorporated not only in sunscreens but also in BB creams and foundations," a company official stated. "We plan to actively target the U.S., the world's No. 1 beauty market, not content with just holding a 70 percent share in the domestic sunscreen product market."
Photo by: Kolmar Website
